PVH Corp. Stock Falls Thursday, Underperforms Market

Spectrum Pharmaceuticals Inc

Change company Symbol lookup

Select an option...

SPPI Spectrum Pharmaceuticals Inc

FDBC Fidelity D&D Bancorp Inc

$BUKCHET Bloomberg Coffee Subindex Euro

BMY Bristol-Myers Squibb Co

MLGO MicroAlgo Inc

FRST Primis Financial Corp

VII 7GC & Holdings Co Inc

PEBO Peoples Bancorp Inc

BIOAF Bioasis Technologies Inc

NRGOF Newrange Gold Corp

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value

Company profile

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. The Company's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a, pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. The Eflapegrastim employs a LAPSCOVERY technology to enhance the duration of therapeutic effects and reduce the frequency of administration.

PVH Corp. Stock Falls Thursday, Underperforms Market

5:19 pm ET October 27, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of PVH Corp. (PVH) slipped 1.62% to $51.50 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.61% to 32,033.28 and the S&P 500 Index falling 0.61% to 3,807.30. The stock's fall snapped a four-day winning streak. PVH Corp. closed $73.92 below its 52-week high ($125.42), which the company achieved on November 5th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as VF Corp. (VFC) fell 2.80% to $27.42, Ralph Lauren Corp. Cl A (RL) fell 1.82% to $91.82, and Hanesbrands Inc. (HBI) fell 0.14% to $7.36. Trading volume (938,997) remained 646,877 below its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled October 27, 2022.

(END) Dow Jones Newswires

October 27, 2022 17:19 ET (21:19 GMT)